Treatment

Dose (mg/kg b.w.)

Increase in Paw edema volume (mL)

Inhibition (%)

1 H

3 H

5 H

1 H

3 H

5 H

Control

-

0.40 ± 0.03

0.50 ± 0.03

0.60 ± 0.04

-

-

-

AAS

100

0.17 ± 0.00^a

0.17 ± 0.02^a

0.08 ± 0.01^a

57.7 ± 0.5

64.8 ± 4.0

87.0 ± 2.3

DEC

200

0.30 ± 0.03^b

0.26 ± 0.01^b

0.22 ± 0.02^b

26.4 ± 2.3^b

47.7 ± 1.7^b

63.9 ± 3.8^b

DEC

400

0.26 ± 0.02^b

0.21 ± 0.01^b

0.14 ± 0.02^b

36.4 ± 2.5^d

58.5 ± 1.9^d

76.0 ± 3.4^d

DEC

600

0.23 ± 0.03^a

0.14 ± 0.03^a

0.10 ± 0.03^a

42.3 ± 3.9 ^$

75.9 ± 3.2^$

82.8 ± 2.8^$

MAC

200

0.36 ± 0.02^d

0.33 ± 0.01^d

0.33 ± 0.03^d

9.3 ± 3.9^a

33.7 ± 1.6^a

45.0 ± 4.4^a

MAC

400

0.25 ± 0.03^a

0.20 ± 0.05^a

0.12 ± 0.01^a

33.7 ± 3.1^d

54.3 ± 1.9^d

79.4 ± 2.5^d

MAC

600

0.20 ± 0.01^a

0.15 ± 0.01^a

0.1 ± 0.02^a

49.8 ± 3.6^$

69.4 ± 1.4^$

84.1 ± 2.8^$